Mssrs. Divis and Hatfield,
We join together today to call on KV Pharmaceuticals to lower the price of Makena, your newly-approved drug used to prevent pre-term birth
Prior to Makena’s approval, the same progesterone treatment was widely available through compounding pharmacies for $10 – $20 per dose. We note your price reduction from the original, shocking, $1,500 to per does to the current list price of $690 per dose as a step in the right direction. At approximately $10,000 for a course of treatment, however, the new price still poses an unreasonable burden on patients and the healthcare system.